| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:1307932 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CLDN4 mRNA | CTD | PMID:20551477 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1317414 | 6480464 | Ethinyl Estradiol results in increased expression of CLDN4 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1317414 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLDN4 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CLDN4 mRNA | CTD | PMID:16474171 |
| 17beta-estradiol | affects expression | ISO | RGD:1317414 | 6480464 | Estradiol affects the expression of CLDN4 mRNA | CTD | PMID:15598610 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CLDN4 protein | CTD | PMID:21761342 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1317414 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLDN4 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1317414 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CLDN4 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1317414 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CLDN4 mRNA | CTD | PMID:17942748 |
| 2-acetamidofluorene | increases expression | ISO | RGD:1307932 | 6480464 | 2-Acetylaminofluorene results in increased expression of CLDN4 mRNA | CTD | PMID:17187413 |
| 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of CLDN4 mRNA | CTD | PMID:16671099 |
| 5-fluorouracil | affects response to substance | EXP | | 6480464 | CLDN4 protein affects the susceptibility to Fluorouracil | CTD | PMID:15352031 |
| 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of CLDN4 protein | CTD | PMID:15352031 |
| aflatoxin B1 | increases expression | ISO | RGD:1317414 | 6480464 | Aflatoxin B1 results in increased expression of CLDN4 mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1317414 | 6480464 | Tretinoin results in increased expression of CLDN4 mRNA | CTD | PMID:16236135 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1307932 | 6480464 | Tretinoin results in increased expression of CLDN4 mRNA | CTD | PMID:20488242 |
| arsenite(3-) | increases expression | ISO | RGD:1317414 | 6480464 | arsenite results in increased expression of CLDN4 mRNA | CTD | PMID:18191166 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CLDN4 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CLDN4 mRNA | CTD | PMID:20106945 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CLDN4 mRNA | CTD | PMID:20106945 PMID:22316170 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1317414 | 6480464 | Benzo(a)pyrene results in decreased expression of CLDN4 mRNA | CTD | PMID:19770486 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CLDN4 mRNA | CTD | PMID:16474171 |
| choline | multiple interactions | ISO | RGD:1317414 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLDN4 mRNA | CTD | PMID:20938992 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of CLDN4 mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN4 mRNA | CTD | PMID:19167446 |
| cyclosporin A | increases expression | ISO | RGD:1307932 | 6480464 | Cyclosporine results in increased expression of CLDN4 mRNA | CTD | PMID:21865292 |
| cyclosporin A | decreases expression | ISO | RGD:1307932 | 6480464 | Cyclosporine results in decreased expression of CLDN4 mRNA | CTD | PMID:21865292 |
| diallyl disulfide | decreases expression | EXP | | 6480464 | diallyl disulfide results in decreased expression of CLDN4 protein; more ... | CTD | PMID:20600798 |
| diarsenic trioxide | decreases response to substance | EXP | | 6480464 | CLDN4 protein results in decreased susceptibility to arsenic trioxide | CTD | PMID:20707922 |
| doxorubicin | affects expression | ISO | RGD:1317414 | 6480464 | Doxorubicin affects the expression of CLDN4 mRNA | CTD | PMID:15033991 |
| elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of CLDN4 mRNA | CTD | PMID:19244175 |
| folic acid | multiple interactions | ISO | RGD:1317414 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLDN4 mRNA | CTD | PMID:20938992 |
| genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of CLDN4 mRNA | CTD | PMID:16474171 |
| L-methionine | multiple interactions | ISO | RGD:1317414 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLDN4 mRNA | CTD | PMID:20938992 |
| leuprolide | decreases expression | EXP | | 6480464 | Leuprolide results in decreased expression of CLDN4 protein | CTD | PMID:21761342 |
| naphthalene | increases expression | ISO | RGD:1317414 | 6480464 | naphthalene results in increased expression of CLDN4 mRNA | CTD | PMID:18978301 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CLDN4 mRNA | CTD | PMID:19945525 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1317414 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CLDN4 mRNA | CTD | PMID:19945525 |
| phosgene | affects expression | ISO | RGD:1317414 | 6480464 | Phosgene affects the expression of CLDN4 mRNA | CTD | PMID:16300373 |
| pirinixic acid | decreases expression | ISO | RGD:1317414 | 6480464 | pirinixic acid results in decreased expression of CLDN4 mRNA | CTD | PMID:17426115 |
| progesterone | decreases expression | EXP | | 6480464 | Progesterone results in decreased expression of CLDN4 mRNA | CTD | PMID:18037150 |
| progesterone | affects expression | ISO | RGD:1317414 | 6480464 | Progesterone affects the expression of CLDN4 mRNA | CTD | PMID:17251523 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of CLDN4 mRNA; more ... | CTD | PMID:18492835 |
| sanguinarine | decreases expression | EXP | | 6480464 | sanguinarine results in decreased expression of CLDN4 protein | CTD | PMID:19063874 |
| selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of CLDN4 mRNA | CTD | PMID:19244175 |
| tacrolimus hydrate | increases expression | ISO | RGD:1307932 | 6480464 | Tacrolimus results in increased expression of CLDN4 mRNA | CTD | PMID:21865292 |
| tamoxifen | affects response to substance | EXP | | 6480464 | CLDN4 affects the susceptibility to Tamoxifen | CTD | PMID:19142967 |
| testosterone | decreases expression | EXP | | 6480464 | Testosterone deficiency results in decreased expression of CLDN4 mRNA | CTD | PMID:21761342 |
| testosterone | affects expression | ISO | RGD:1317414 | 6480464 | Testosterone affects the expression of CLDN4 protein | CTD | PMID:21761342 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CLDN4 mRNA; more ... | CTD | PMID:19285010 |
| tunicamycin | increases expression | ISO | RGD:1317414 | 6480464 | Tunicamycin results in increased expression of CLDN4 mRNA | CTD | PMID:17127020 |
| vanadyl sulfate | increases expression | EXP | | 6480464 | vanadyl sulfate results in increased expression of CLDN4 mRNA | CTD | PMID:16330358 |